News-Medical.Net on MSN
Investigational anti-clotting drug reduces risk of second ischemic stroke without bleeding concerns
An investigational anti-clotting medication, asundexian, demonstrated a reduction in the risk of a second ischemic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results